Apoptosis in mammary gland and cancer

Endocrine-Related Cancer

Volumn 7, Issue 4, 2000, Pages 257-269

  Kumar, R ^a   Vadlamudi, R K ^a   Adam, L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ESTRADIOL; FAS LIGAND; GESTAGEN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CELL LOSS; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; MAMMARY GLAND; PROTEIN FAMILY; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; FAS LIGAND PROTEIN; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS;

EID: 0034471826     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0070257     Document Type: Review

References (115)

1. Expression of bcl-2 by breast cancer: A possible diagnostic application
2. Down-regulation of protein tyrosine phosphatase gene expression in lactating mouse mammary gland
3. Gene expression during involution of mammary gland
4. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
5. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis
6. Caspase activation in MCF7 cells responding to etoposide treatment
7. Transcription factors and breast cancer
8. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line
9. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
10. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers
11. Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
12. Apoptosis and disease
13. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of stat3
14. NF-kappaB and apoptosis in mammary epithelial cells
15. NF-KappaB inhibits apoptosis in murine mammary epithelia
16. Postnatal development of the rodent mammary gland
17. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line
18. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
19. Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells
20. Specificity of tissue interaction and origin of mesenchymal cells in the androgen response of the embryonic mammary gland
21. Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis
22. Regulators of apoptosis in human breast cancer
23. Expression of a 74-kDa nuclear factor 1 (NF1) protein is induced in mouse mammary gland involution. Involution-enhanced occupation of a twin NF1 binding element in the testosterone-repressed prostate message-2/clusterin promoter
24. Local signals induce CCAAT/enhancer binding protein-delta (C/EBP-delta) and C/EBP-beta mRNA expression in the involuting mouse mammary gland
25. Induction of gene expression during involution of the lactating mammary gland of the rat
26. The Fas/Fas-ligand system: A mechanism for immune evasion in human breast carcinomas
27. Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells
28. Hormonal chemoprevention of cancer in women
29. Apoptosis induced by anticancer drugs
30. Bcl2 is an inner mitochondrial membrane protein that blocks programmed cell death
31. Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death
32. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis
33. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice
34. Regulation of a physiological apoptosis: Mouse mammary involution
35. Regulation of p53 and its targets during involution of the mammary gland
36. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells
37. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients
38. Fas expression and function in normal and malignant breast cell lines
39. The epidemiology of breast cancer
40. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect
41. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
42. Bcl2 initiates a new category of oncogenes: Regulator of cell death
43. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
44. Analysis of Box and Bcl-2 expression in p53- immunopositive breast cancers
45. Prognostic significance of apoptosis regulators in breast cancer
46. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells
47. Iron metabolism-related genes and mitochondrial genes are induced during involution of mouse mammary gland
48. Bax degradation by the ubiquitin/proteosome dependent pathway: Involvement of tumor survival and progression
49. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways
50. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution
51. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein
52. Induction of apoptosis and inhibition of c-erbB2 in breast cancer cells by flavopiridol
53. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane
54. Interaction of BAG1 with retinoic acid receptor and its inhibition of retinoic acid induced apoptosis in cancer cells
55. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways
56. Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells
57. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells
58. Transcription factor activities and gene expression during mouse mammary gland involution
59. The mammary gland: A unique organ for the study of development and tumorigenesis
60. Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland
61. Prognostic relevance of altered Fas (CD95)-system in human breast cancer
62. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells
63. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer
64. Hormonal control of mammogenesis and lactogenesis in the C3H/He Crg1 mouse
65. Expression of Bcl-2 like immunoreactivity in the normal breast and in breast cancer
66. Bcl2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death
67. Steroid receptor interactions with heat shock protein and immunophilin chaperones
68. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
69. Bcl2 and the regulation of programmed cell death
70. FasL: Fas ratio - A prognostic factor in breast carcinomas
71. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7 (ADR) breast-cancer cells
72. Structural changes associated with inhibition of involution of the mammary gland in the albino rat
73. The role of ovarian hormones, age and mammary gland development in polymavirus mammary tumorigenesis
74. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence
75. Differentiation of the mammary gland and susceptibility to carcinogenesis
76. Bcl-2 expression in normal breast tissue during the menstrual cycle
77. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
78. Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide
79. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity
80. Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding beta-casein
81. Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis
82. Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo
83. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer
84. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
85. Bcl-2 inhibits multiple forms of apoptosis but not negative selective in thymocytes
86. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV-40-Tag transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage
87. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferate activity
88. Mechanisms and genes of cellular suicide
89. Apoptotic cell death and tissue remodeling during mouse mammary gland involution
90. Programmed cell death during mammary gland involution
91. Stat5 as a target for regulation by extracellular matrix
92. Overexpression of Bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis
93. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity
94. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
95. Estrogen promotes chemotherapeutical drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells
96. Apoptosis in the pathogenesis and treatment of disease
97. Multiple hormone interactions in the developmental biology of the mammary gland
98. The t(14:18) chromosome translocation involved in B-cell neoplasms results from mistake in VDJ joining
99. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells
100. Characterization of the subcellular localization of BAG1 protein in human breast cancer
101. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors
102. Nitric oxide mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95
103. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
104. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
105. Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis
106. Bcl-2 interacting protein Bag-1 binds to and activates the kinase Raf-1
107. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells
108. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
109. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors
110. Molecular regulation of apoptosis: Genetic controls on cell death
111. Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues
112. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
113. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas
114. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not Bax and Bcl-X (L), without alteration of p53 protein levels